A role for TGFbeta(1) in osteoclast differentiation and survival

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Fuller, K.
	Articles by Chambers, T. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Fuller, K.
	Articles by Chambers, T. J.


Social Bookmarking

	What's this?

Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D. and Galibert, L (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.[Medline]

Bogdan, C. and Nathan, C (1993). Modulation of macrophage function by transforming growth factor, interleukin-4, and interleukin-10. Ann. NY Acad. Sci 685, 713-739.[Medline]

Bonewald, L. F. and Dallas, S. L (1994). Role of active and latent transforming growth factorin bone formation. J. Cell Biochem 55, 350-357.[Medline]

Bonewald, L. F. and Mundy, G. R (1990). Role of transforming growth factor-beta in bone remodeling. Clin. Orth. Rel. Res 250, 261-276.

Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., Boyle, W. J. and Simonet, W. S (1998). Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12, 1260-1268.[Abstract/Free Full Text]

Burstone, M. S (1958). Histochemical demonstration of acid phosphatases with naphthol AS-phosphate. J. Natl. Cancer Inst 21, 423-539.

Centrella, M., Horowitz, M. C., Wozney, J. M. and McCarthy, T. L (1994). Transforming growth factor-gene family members and bone. Endocr. Rev 15, 27-39.[Abstract/Free Full Text]

Chenu, C., Pfeilschifter, J., Mundy, G. R. and Roodman, G. D (1988). Transforming growth factorinhibits formation of osteoclast-like cells inlong-term human marrow cultures. Proc. Natl. Acad. Sci. USA 85, 5683-5687.[Abstract/Free Full Text]

Chomczynski, P. and Sacchi, N (1987). Single-step method of RNA isolation by acid guanidinium-thiocynate-phenol-chloroform extraction. Anal. Biochem 162, 156-159.[Medline]

Dieudonne, S. C., Foo, P., van Zoelen, E. J. J. and Burger, E. H (1991). Inhibiting and stimulating effects of TGF-1 on osteoclastic bone resorption in fetal mouse bone organ cultures. J. Bone Min. Res 6, 479-487.[Medline]

Emery, J. G., McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., Dodds, R. A., James, I. E., Rosenberg, M., Lee, J. C. and Young, P. R (1998). Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem 273, 14363-14367.[Abstract/Free Full Text]

Erlebacher, A. and Derynck, R (1996). Increased expression of TGF-2 in osteoblasts results in an osteoporosis-like phenotype. J. Cell Biol 132, 195-210.[Abstract/Free Full Text]

Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y. and Henson, P. M (1998). Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-, PGE2 and PAF. J. Clin. Invest 101, 890-898.[Medline]

Fuller, K., Owens, J. M., Jagger, C. J., Wilson, A., Moss, R. and Chambers, T. J (1993). Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med 178, 1733-1744.[Abstract/Free Full Text]

Fuller, K., Wong, B., Fox, S., Choi, Y. and Chambers, T. J (1998). TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J. Exp. Med 188, 997-1001.[Abstract/Free Full Text]

Goerdt, S. and Orfanos, C. E (1999). Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142.[Medline]

Hattersley, G. and Chambers, T. J (1991). Effects of transforming growth factor1on the regulation of osteoclastic development and function. J. Bone Min. Res 6, 165-172.[Medline]

Hauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E. and Klagsbrun, M (1986). Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J. Biol. Chem 261, 12665-12674.[Abstract/Free Full Text]

Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., Wang, L., Xia, X.-Z., Elliott, R., Ciu, L., Black, T., Scully, S., Capparelli, C., Morony, S., Shimamoto, G., Bass, M. B. and Boyle, W. J (1999). Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induved by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96, 3540-3545.[Abstract/Free Full Text]

Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R. and Boyce, B. F (1996). Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-. Nat. Med 2, 1132-1136.[Medline]

Jimi, E., Akiyama, S., Tsurukai, T., Okahashi, N., Kobayashi, K., Udagawa, N., Nishihara, T., Takahashi, N. and Suda, T (1999). Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol 163, 434-442.[Abstract/Free Full Text]

Joyce, M. E., Roberts, A. B., Sporn, M. B. and Bolander, M. E (1990). Transforming growth factor-and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol 110, 2195-2207.[Abstract/Free Full Text]

Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., Wakeham, A., Dunstan, C. R., Lacey, D. L., Mak, T. W., Boyle, W. J. and Penninger, J. M (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.[Medline]

Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T. E., R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J. and Boyle, W. J (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.[Medline]

Letterio, J. J. and Roberts, A. B (1998). Regulation of immune responses by TGF-. Ann. Rev. Immunol 16, 137-161.[Medline]

Marcelli, C., Yates, A. J. and Mundy, G. R (1990). In vivo effects of human recombinant transforming growth factoron bone turnover in normal mice. J. Bone Min. Res 5, 1087-1096.[Medline]

Massaque, J (1990). The transforming growth factor-beta family. Ann. Rev. Cell Biol 6, 597-609.

McSheehy, P. M. J. and Chambers, T. J (1986). Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118, 824-828.[Abstract/Free Full Text]

Munn, D. H., Beall, A. C., Song, D., Wrenn, R. W. and Throckmorton, D. C (1995). Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon. J. Exp. Med 181, 127-136.[Abstract/Free Full Text]

Murakami, T., Yamamoto, M., Yamamoto, M., Ono, K., Nishikawa, M., Nagata, N., Motoyoshi, K. and Akatsu, T (1998). Transforming growth factor-1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem. Biophys. Res. Comm 252, 747-752.[Medline]

Noble, P. W., Henson, P. M., Lucas, C., Mora-Worms, M., Carre, P. C. and Riches, D. W. H (1993). Transforming growth factor-primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J. Immunol 151, 979-989.[Abstract]

Noda, M. and Camilliere, J. J (1989). In vivo stimulation of bone formation by transforming growth factor-. Endocrinology 124, 2991-2994.[Abstract/Free Full Text]

Parent, J. L. and Stankova, J (1993). Transforming growth factor-beta up-regulates the gene expression of the human platelet-activating factor receptor in monocytic and B cell lines. Biochem. Biophys. Res. Commun 197, 1443-1449.[Medline]

Pelton, R. W., Saxena, B., Jones, M., Moses, H. L. and Gold, L. I (1991). Immunohistochemical localization of TGF-1, TGF- 2, and TGF-3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell Biol 115, 1091-1105.[Abstract/Free Full Text]

Pfeilschifter, J., Seyedin, S. M. and Mundy, G. R (1988). Transforming growth factor beta inhibits resorption in fetal rat long bone cultures. J. Clin. Invest 82, 680-685.

Robey, P. G., Young, M. F., Flanders, K. C., Roche, N. S., Kondaiah, P., Reddi, A., Termine, J. D., Sporn, M. B. and Roberts, A. N (1987). Osteoblasts synthesize and respond to transforming growth factor-type(TGF ) in vitro. J. Cell Biol 105, 457-463.[Abstract/Free Full Text]

Sad, S. and Mosmann, T. R (1994). Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol 153, 3514-3522.[Abstract]

Sallusto, F., Lenig, D., Mackay, C. R. and Lanzavecchia, A (1998). Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med 187, 875-883.[Abstract/Free Full Text]

Sandberg, M., Vuorio, T., Hirvonen, H., Alitalo, K. and Vuorio, E (1988). Enhanced expression of TGFand c-fos mRNA in the growth plates of developing human long bones. Development 102, 461-470.[Abstract]

Sells Galvin, R. J., Gatlin, C. L., Horn, J. W. and Fuson, T. R (1999). TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. Biochem. Biophys. Res. Commun 265, 233-239.[Medline]

Seyedin, S. M., Thompson, A. Y., Bentz, H., Rosen, D. M., McPherson, J. M., Conti, A., Siegel, N. R., Galluppi, G. F. and Piez, K. A (1986). Cartilage-inducing factor-A: apparent identity to transforming growth factor-. J. Biol. Chem 261, 5693-5695.[Abstract/Free Full Text]

Smith, C. A., Farrah, T. and Goodwin, R. G (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962.[Medline]

Suda, T., Takahashi, N. and Martin, T. J (1992). Modulation of osteoclast differentiation. Endocr. Rev 13, 66-79.[Abstract/Free Full Text]

Takai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K. and Yamada, Y (1998). Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J. Biol. Chem 273, 27091-27096.[Abstract/Free Full Text]

Tashjian, A. H., Jr., Voelkel, E. F., Lazzaro, M., Singer, F. R., Roberts, A. B., Derynck, R., Winkler, M. E. and Levine, L (1985). and human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc. Natl. Acad. Sci. USA 82, 4535-4538.[Abstract/Free Full Text]

Tsunawaki, S., Sporn, M., Ding, A. and Nathan, C (1988). Deactivation of macrophages by transforming growth factor-. Nature 334, 260-262.[Medline]

Tushinski, R. J. and Stanley, E. R (1985). The regulation of mononuclear phagocyte entry into S-phase by the colony stimulating factor CSF-1. J. Cell. Physiol 122, 221-228.[Medline]

Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.[Medline]

Wahl, S. M., Allen, J. B., Weeks, B. S., Wong, H. L. and Klotman, P. E (1993). Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA 90, 4577-4581.[Abstract/Free Full Text]

Wani, M. R., Fuller, K., Kim, N. S., Choi, Y. and Chambers, T (1999). Prostaglandin E2cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology 140, 1927-1935.[Abstract/Free Full Text]

Welch, G. R., Wong, H. L. and Wahl, S. M (1990). Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J. Immunol 144, 3444-3448.[Abstract]

Wijfels, J. F. A. M., de Rover, Z., Kraal, G. and Beelen, R. H. J (1993). Macrophage phenotype regulation by colony-stimulating factors at bone marrow level. J. Leukocyte Biol 53, 249-255.[Abstract]

Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H.-L., Steinman, R. M. and Choi, Y (1997). TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med 186, 2075-2080.[Abstract/Free Full Text]

Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett III, F. S., Frankel, W. N., Lee, S. Y. and Choi, Y (1997). TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem 272, 25190-25194.[Abstract/Free Full Text]

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE-RANKL. Proc. Natl. Acad. Sci. USA 95, 3597-3602.[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

N. Houde, E. Chamoux, M. Bisson, and S. Roux
Transforming Growth Factor-{beta}1 (TGF-{beta}1) Induces Human Osteoclast Apoptosis by Up-regulating Bim
J. Biol. Chem., August 28, 2009; 284(35): 23397 - 23404.
[Abstract] [Full Text] [PDF]

V. Munugalavadla, S. Vemula, E. C. Sims, S. Krishnan, S. Chen, J. Yan, H. Li, P. J. Niziolek, C. Takemoto, A. G. Robling, et al.
The p85{alpha} Subunit of Class IA Phosphatidylinositol 3-Kinase Regulates the Expression of Multiple Genes Involved in Osteoclast Maturation and Migration
Mol. Cell. Biol., December 1, 2008; 28(23): 7182 - 7198.
[Abstract] [Full Text] [PDF]

X. Tan, T. Weng, J. Zhang, J. Wang, W. Li, H. Wan, Y. Lan, X. Cheng, N. Hou, H. Liu, et al.
Smad4 is required for maintaining normal murine postnatal bone homeostasis
J. Cell Sci., July 1, 2007; 120(13): 2162 - 2170.
[Abstract] [Full Text] [PDF]

A. Mochizuki, M. Takami, T. Kawawa, R. Suzumoto, T. Sasaki, A. Shiba, H. Tsukasaki, B. Zhao, R. Yasuhara, T. Suzawa, et al.
Identification and Characterization of the Precursors Committed to Osteoclasts Induced by TNF-Related Activation-Induced Cytokine/Receptor Activator of NF-{kappa}B Ligand
J. Immunol., October 1, 2006; 177(7): 4360 - 4368.
[Abstract] [Full Text] [PDF]

K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul
Transforming Growth Factor-{beta}1 to the Bone
Endocr. Rev., October 1, 2005; 26(6): 743 - 774.
[Abstract] [Full Text] [PDF]

N. Kim, Y. Kadono, M. Takami, J. Lee, S.-H. Lee, F. Okada, J. H. Kim, T. Kobayashi, P. R. Odgren, H. Nakano, et al.
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis
J. Exp. Med., September 6, 2005; 202(5): 589 - 595.
[Abstract] [Full Text] [PDF]

L. S. Mangashetti, S. M. Khapli, and M. R. Wani
IL-4 Inhibits Bone-Resorbing Activity of Mature Osteoclasts by Affecting NF-{kappa}B and Ca2+ Signaling
J. Immunol., July 15, 2005; 175(2): 917 - 925.
[Abstract] [Full Text] [PDF]

S. D. Yogesha, S. M. Khapli, and M. R. Wani
Interleukin-3 and Granulocyte-Macrophage Colony-stimulating Factor Inhibits Tumor Necrosis Factor (TNF)-{alpha}-induced Osteoclast Differentiation by Down-regulation of Expression of TNF Receptors 1 and 2
J. Biol. Chem., March 25, 2005; 280(12): 11759 - 11769.
[Abstract] [Full Text] [PDF]

K. Wang, H. Yamamoto, J. R. Chin, Z. Werb, and T. H. Vu
Epidermal Growth Factor Receptor-deficient Mice Have Delayed Primary Endochondral Ossification Because of Defective Osteoclast Recruitment
J. Biol. Chem., December 17, 2004; 279(51): 53848 - 53856.
[Abstract] [Full Text] [PDF]

L. Kenner, A. Hoebertz, T. Beil, N. Keon, F. Karreth, R. Eferl, H. Scheuch, A. Szremska, M. Amling, M. Schorpp-Kistner, et al.
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects
J. Cell Biol., February 16, 2004; 164(4): 613 - 623.
[Abstract] [Full Text] [PDF]

D. O'Gradaigh and J. E. Compston
T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion
Rheumatology, February 1, 2004; 43(2): 122 - 130.
[Full Text] [PDF]

M. A. Karsdal, P. Hjorth, K. Henriksen, T. Kirkegaard, K. L. Nielsen, H. Lou, J.-M. Delaisse, and N. T. Foged
Transforming Growth Factor-{beta} Controls Human Osteoclastogenesis through the p38 MAPK and Regulation of RANK Expression
J. Biol. Chem., November 7, 2003; 278(45): 44975 - 44987.
[Abstract] [Full Text] [PDF]

D. V. Novack, L. Yin, A. Hagen-Stapleton, R. D. Schreiber, D. V. Goeddel, F. P. Ross, and S. L. Teitelbaum
The I{kappa}B Function of NF-{kappa}B2 p100 Controls Stimulated Osteoclastogenesis
J. Exp. Med., September 2, 2003; 198(5): 771 - 781.
[Abstract] [Full Text] [PDF]

N. W. A. McGowan, H. MacPherson, K. Janssens, W. Van Hul, J. C. Frith, W. D. Fraser, S. H. Ralston, and M. H. Helfrich
A Mutation Affecting the Latency-Associated Peptide of TGF{beta}1 in Camurati-Engelmann Disease Enhances Osteoclast Formation in Vitro
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3321 - 3326.
[Abstract] [Full Text] [PDF]

S. M. Khapli, L. S. Mangashetti, S. D. Yogesha, and M. R. Wani
IL-3 Acts Directly on Osteoclast Precursors and Irreversibly Inhibits Receptor Activator of NF-{kappa}B Ligand-Induced Osteoclast Differentiation by Diverting the Cells to Macrophage Lineage
J. Immunol., July 1, 2003; 171(1): 142 - 151.
[Abstract] [Full Text] [PDF]

S. W. Fox, S. J. Haque, A. C. Lovibond, and T. J. Chambers
The Possible Role of TGF-{beta}-Induced Suppressors of Cytokine Signaling Expression in Osteoclast/Macrophage Lineage Commitment In Vitro
J. Immunol., April 1, 2003; 170(7): 3679 - 3687.
[Abstract] [Full Text] [PDF]

K. Fuller, C. Murphy, B. Kirstein, S. W. Fox, and T. J. Chambers
TNF{alpha} Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL
Endocrinology, March 1, 2002; 143(3): 1108 - 1118.
[Abstract] [Full Text] [PDF]

N. Kim, M. Takami, J. Rho, R. Josien, and Y. Choi
A Novel Member of the Leukocyte Receptor Complex Regulates Osteoclast Differentiation
J. Exp. Med., January 14, 2002; 195(2): 201 - 209.
[Abstract] [Full Text] [PDF]

K. Itoh, N. Udagawa, T. Katagiri, S. Iemura, N. Ueno, H. Yasuda, K. Higashio, J. M. W. Quinn, M. T. Gillespie, T. J. Martin, et al.
Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-{kappa}B Ligand
Endocrinology, August 1, 2001; 142(8): 3656 - 3662.
[Abstract] [Full Text] [PDF]

B. A. Watkins, Y. Li, H. E. Lippman, and M. F. Seifert
Omega-3 Polyunsaturated Fatty Acids and Skeletal Health
Experimental Biology and Medicine, June 1, 2001; 226(6): 485 - 497.
[Abstract] [Full Text] [PDF]

A. HOEBERTZ, S. MEGHJI, G. BURNSTOCK, and T. R. ARNETT
Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y1 receptor on bone cells
FASEB J, May 1, 2001; 15(7): 1139 - 1148.
[Abstract] [Full Text] [PDF]

S. W. Fox, K. Fuller, K. E. Bayley, J. M. Lean, and T. J. Chambers
TGF-{beta}1 and IFN-{gamma} Direct Macrophage Activation by TNF-{alpha} to Osteoclastic or Cytocidal Phenotype
J. Immunol., November 1, 2000; 165(9): 4957 - 4963.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Fuller, K.

Articles by Chambers, T. J.

Search for Related Content

PubMed

PubMed Citation

Articles by Fuller, K.

Articles by Chambers, T. J.

Social Bookmarking

What's this?

				V. Munugalavadla, S. Vemula, E. C. Sims, S. Krishnan, S. Chen, J. Yan, H. Li, P. J. Niziolek, C. Takemoto, A. G. Robling, et al. The p85{alpha} Subunit of Class IA Phosphatidylinositol 3-Kinase Regulates the Expression of Multiple Genes Involved in Osteoclast Maturation and Migration Mol. Cell. Biol., December 1, 2008; 28(23): 7182 - 7198. [Abstract] [Full Text] [PDF]

				X. Tan, T. Weng, J. Zhang, J. Wang, W. Li, H. Wan, Y. Lan, X. Cheng, N. Hou, H. Liu, et al. Smad4 is required for maintaining normal murine postnatal bone homeostasis J. Cell Sci., July 1, 2007; 120(13): 2162 - 2170. [Abstract] [Full Text] [PDF]

				A. Mochizuki, M. Takami, T. Kawawa, R. Suzumoto, T. Sasaki, A. Shiba, H. Tsukasaki, B. Zhao, R. Yasuhara, T. Suzawa, et al. Identification and Characterization of the Precursors Committed to Osteoclasts Induced by TNF-Related Activation-Induced Cytokine/Receptor Activator of NF-{kappa}B Ligand J. Immunol., October 1, 2006; 177(7): 4360 - 4368. [Abstract] [Full Text] [PDF]

				K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF]

				N. Kim, Y. Kadono, M. Takami, J. Lee, S.-H. Lee, F. Okada, J. H. Kim, T. Kobayashi, P. R. Odgren, H. Nakano, et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis J. Exp. Med., September 6, 2005; 202(5): 589 - 595. [Abstract] [Full Text] [PDF]

				L. S. Mangashetti, S. M. Khapli, and M. R. Wani IL-4 Inhibits Bone-Resorbing Activity of Mature Osteoclasts by Affecting NF-{kappa}B and Ca2+ Signaling J. Immunol., July 15, 2005; 175(2): 917 - 925. [Abstract] [Full Text] [PDF]

				S. D. Yogesha, S. M. Khapli, and M. R. Wani Interleukin-3 and Granulocyte-Macrophage Colony-stimulating Factor Inhibits Tumor Necrosis Factor (TNF)-{alpha}-induced Osteoclast Differentiation by Down-regulation of Expression of TNF Receptors 1 and 2 J. Biol. Chem., March 25, 2005; 280(12): 11759 - 11769. [Abstract] [Full Text] [PDF]

				K. Wang, H. Yamamoto, J. R. Chin, Z. Werb, and T. H. Vu Epidermal Growth Factor Receptor-deficient Mice Have Delayed Primary Endochondral Ossification Because of Defective Osteoclast Recruitment J. Biol. Chem., December 17, 2004; 279(51): 53848 - 53856. [Abstract] [Full Text] [PDF]

				L. Kenner, A. Hoebertz, T. Beil, N. Keon, F. Karreth, R. Eferl, H. Scheuch, A. Szremska, M. Amling, M. Schorpp-Kistner, et al. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects J. Cell Biol., February 16, 2004; 164(4): 613 - 623. [Abstract] [Full Text] [PDF]

				D. O'Gradaigh and J. E. Compston T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion Rheumatology, February 1, 2004; 43(2): 122 - 130. [Full Text] [PDF]

				M. A. Karsdal, P. Hjorth, K. Henriksen, T. Kirkegaard, K. L. Nielsen, H. Lou, J.-M. Delaisse, and N. T. Foged Transforming Growth Factor-{beta} Controls Human Osteoclastogenesis through the p38 MAPK and Regulation of RANK Expression J. Biol. Chem., November 7, 2003; 278(45): 44975 - 44987. [Abstract] [Full Text] [PDF]

				D. V. Novack, L. Yin, A. Hagen-Stapleton, R. D. Schreiber, D. V. Goeddel, F. P. Ross, and S. L. Teitelbaum The I{kappa}B Function of NF-{kappa}B2 p100 Controls Stimulated Osteoclastogenesis J. Exp. Med., September 2, 2003; 198(5): 771 - 781. [Abstract] [Full Text] [PDF]

				N. W. A. McGowan, H. MacPherson, K. Janssens, W. Van Hul, J. C. Frith, W. D. Fraser, S. H. Ralston, and M. H. Helfrich A Mutation Affecting the Latency-Associated Peptide of TGF{beta}1 in Camurati-Engelmann Disease Enhances Osteoclast Formation in Vitro J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3321 - 3326. [Abstract] [Full Text] [PDF]

				S. M. Khapli, L. S. Mangashetti, S. D. Yogesha, and M. R. Wani IL-3 Acts Directly on Osteoclast Precursors and Irreversibly Inhibits Receptor Activator of NF-{kappa}B Ligand-Induced Osteoclast Differentiation by Diverting the Cells to Macrophage Lineage J. Immunol., July 1, 2003; 171(1): 142 - 151. [Abstract] [Full Text] [PDF]

				S. W. Fox, S. J. Haque, A. C. Lovibond, and T. J. Chambers The Possible Role of TGF-{beta}-Induced Suppressors of Cytokine Signaling Expression in Osteoclast/Macrophage Lineage Commitment In Vitro J. Immunol., April 1, 2003; 170(7): 3679 - 3687. [Abstract] [Full Text] [PDF]

				K. Fuller, C. Murphy, B. Kirstein, S. W. Fox, and T. J. Chambers TNF{alpha} Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL Endocrinology, March 1, 2002; 143(3): 1108 - 1118. [Abstract] [Full Text] [PDF]

				N. Kim, M. Takami, J. Rho, R. Josien, and Y. Choi A Novel Member of the Leukocyte Receptor Complex Regulates Osteoclast Differentiation J. Exp. Med., January 14, 2002; 195(2): 201 - 209. [Abstract] [Full Text] [PDF]

				K. Itoh, N. Udagawa, T. Katagiri, S. Iemura, N. Ueno, H. Yasuda, K. Higashio, J. M. W. Quinn, M. T. Gillespie, T. J. Martin, et al. Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-{kappa}B Ligand Endocrinology, August 1, 2001; 142(8): 3656 - 3662. [Abstract] [Full Text] [PDF]

				B. A. Watkins, Y. Li, H. E. Lippman, and M. F. Seifert Omega-3 Polyunsaturated Fatty Acids and Skeletal Health Experimental Biology and Medicine, June 1, 2001; 226(6): 485 - 497. [Abstract] [Full Text] [PDF]

				A. HOEBERTZ, S. MEGHJI, G. BURNSTOCK, and T. R. ARNETT Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y1 receptor on bone cells FASEB J, May 1, 2001; 15(7): 1139 - 1148. [Abstract] [Full Text] [PDF]

				S. W. Fox, K. Fuller, K. E. Bayley, J. M. Lean, and T. J. Chambers TGF-{beta}1 and IFN-{gamma} Direct Macrophage Activation by TNF-{alpha} to Osteoclastic or Cytocidal Phenotype J. Immunol., November 1, 2000; 165(9): 4957 - 4963. [Abstract] [Full Text] [PDF]